Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Unami Mathebula"'
Autor:
Andrew F. Auld, Katherine Fielding, Tefera Agizew, Alice Maida, Anikie Mathoma, Rosanna Boyd, Anand Date, Sherri L. Pals, George Bicego, Yuliang Liu, Ray W. Shiraishi, Peter Ehrenkranz, Christopher Serumola, Unami Mathebula, Heather Alexander, Salome Charalambous, Courtney Emerson, Goabaone Rankgoane-Pono, Pontsho Pono, Alyssa Finlay, James C. Shepherd, Charles Holmes, Tedd V. Ellerbrock, Alison D. Grant
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-19 (2020)
Abstract Background Clinical scores to determine early (6-month) antiretroviral therapy (ART) mortality risk have not been developed for sub-Saharan Africa (SSA), home to 70% of people living with HIV. In the absence of validated scores, WHO eligibil
Externí odkaz:
https://doaj.org/article/c30a82d4dc744756a059289d3ee29aca
Autor:
Andrew F. Auld, Tefera Agizew, Anikie Mathoma, Rosanna Boyd, Anand Date, Sherri L. Pals, Christopher Serumola, Unami Mathebula, Heather Alexander, Tedd V. Ellerbrock, Goabaone Rankgoane-Pono, Pontsho Pono, James C. Shepherd, Katherine Fielding, Alison D. Grant, Alyssa Finlay
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-14 (2020)
Abstract Background Undiagnosed tuberculosis (TB) remains the most common cause of HIV-related mortality. Xpert MTB/RIF (Xpert) is being rolled out globally to improve TB diagnostic capacity. However, previous Xpert impact trials have reported that h
Externí odkaz:
https://doaj.org/article/79c847ee9cc842b2a8676ad1e205ed91
Autor:
Tefera Agizew, Violet Chihota, Sambayawo Nyirenda, Zegabriel Tedla, Andrew F. Auld, Unami Mathebula, Anikie Mathoma, Rosanna Boyd, Anand Date, Sherri L. Pals, Phenyo Lekone, Alyssa Finlay
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Xpert® MTB/RIF (Xpert) has high sensitivity for diagnosing tuberculosis (TB) compared to sputum-smear microscopy (smear) and can reduce time-to-diagnosis, time-to-treatment and potentially unfavorable patient-level treatment outc
Externí odkaz:
https://doaj.org/article/eefae19ab8a44fe1b5d5b8038d0f2c80
Autor:
Andrew F Auld, Andrew D Kerkhoff, Yasmeen Hanifa, Robin Wood, Salome Charalambous, Yuliang Liu, Tefera Agizew, Anikie Mathoma, Rosanna Boyd, Anand Date, Ray W Shiraishi, George Bicego, Unami Mathebula-Modongo, Heather Alexander, Christopher Serumola, Goabaone Rankgoane-Pono, Pontsho Pono, Alyssa Finlay, James C Shepherd, Tedd V Ellerbrock, Alison D Grant, Katherine Fielding
Publikováno v:
PLoS Medicine, Vol 18, Iss 9, p e1003739 (2021)
BackgroundAmong people living with HIV (PLHIV), more flexible and sensitive tuberculosis (TB) screening tools capable of detecting both symptomatic and subclinical active TB are needed to (1) reduce morbidity and mortality from undiagnosed TB; (2) fa
Externí odkaz:
https://doaj.org/article/deb3c013f0fb440ca03db50f41e86ca7
Autor:
Tefera Agizew, Rosanna Boyd, Unami Mathebula, Anikie Mathoma, Joyce Basotli, Christipher Serumola, Sherri Pals, Alyssa Finlay, Phenyo Lekone, Goabaone Rankgoane-Pono, Thato Tlhakanelo, Violet Chihota, Andrew F Auld
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234646 (2020)
BackgroundPatients with non-tuberculous mycobacteria (NTM) or Mycobacterium tuberculosis (MTB) pulmonary disease may have similar clinical presentation. The potential for misdiagnosis and inappropriate treatment exists in settings with limited testin
Externí odkaz:
https://doaj.org/article/f5b99e6ff33d468095fd66981956d249
Autor:
Onani Zimba, Tsaone Tamuhla, Joyce Basotli, Gaoraelwe Letsibogo, Sherri Pals, Unami Mathebula, Anikie Mathoma, Christopher Serumola, Kitso Ramogale, Rosanna Boyd, Tiffany Tran, Alyssa Finlay, Andrew Auld, Anand Date, Heather Alexander, Violet Chihota, Tefera Agizew
Publikováno v:
The Pan African Medical Journal, Vol 33, Iss 110 (2019)
INTRODUCTION: The World Health Organization endorsed (2010) the use of Xpert MTB/RIF and countries are shifting from smear microscopy (smear)-based to Xpert MTB/RIF-based tuberculosis (TB) diagnostic algorithms. As with smear, sputum quality may pred
Externí odkaz:
https://doaj.org/article/52ccba4885374c6380b8009999c2fa91
Autor:
Tefera Agizew, Rosanna Boyd, Ndwapi Ndwapi, Andrew Auld, Joyce Basotli, Sambayawo Nyirenda, Zegabriel Tedla, Anikie Mathoma, Unami Mathebula, Chawangwa Lesedi, Sherri Pals, Anand Date, Heather Alexander, Thomas Kuebrich, Alyssa Finlay
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183237 (2017)
In 2011, the Botswana National Tuberculosis Program adopted World Health Organization guidelines and introduced Xpert MTB/RIF (Xpert) assay to support intensified case finding among people living with HIV enrolling in care. An evaluation was designed
Externí odkaz:
https://doaj.org/article/b9301055f784423ab3fdd161f67f00f4
Autor:
Tefera Agizew, Joyce Basotli, Heather Alexander, Rosanna Boyd, Gaoraelwe Letsibogo, Andrew Auld, Sambayawo Nyirenda, Zegabriel Tedla, Anikie Mathoma, Unami Mathebula, Sherri Pals, Anand Date, Alyssa Finlay
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189981 (2017)
BACKGROUND:Non-tuberculous mycobacteria (NTM) can cause pulmonary infection and disease especially among people living with HIV (PLHIV). PLHIV with NTM disease may clinically present with one of the four symptoms consistent with tuberculosis (TB). We
Externí odkaz:
https://doaj.org/article/f7c5cc1c3ac04a1bbeaae0b6462bed26
Autor:
Allan W. Taylor, Barudi Mosimaneotsile, Unami Mathebula, Anikie Mathoma, Ritah Moathlodi, Irene Theebetsile, Taraz Samandari
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 2013 (2013)
Objective. While 6- to 12-month courses of isoniazid for tuberculosis prevention are considered safe in pregnant women, the effects of longer-term isoniazid prophylaxis or isoniazid in combination with antiretroviral therapy (ART) are not established
Externí odkaz:
https://doaj.org/article/971d4bfc53fb4c50a50f626637c5f475
Autor:
Deborah A Gust, Barudi Mosimaneotsile, Unami Mathebula, Balladiah Chingapane, Zaneta Gaul, Sherri L Pals, Taraz Samandari
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e18435 (2011)
Participant non-adherence and loss to follow-up can compromise the validity of clinical trial results. An assessment of these issues was made in a 3-year tuberculosis prevention trial among HIV-infected adults in Botswana.Between 11/2004-07/2006, 199
Externí odkaz:
https://doaj.org/article/d5fd9618844249d2b8cf50440cec5985